EdiGene and Neukio Enter Collaboration to Develop Next-Generation Immune Cell...
BEIJING & SHANGHAI & CAMBRIDGE, Mass. EdiGene, Inc., a global biotechnology company focused on translating gene-editing technologies into transformative therapies for patients with serious...
View ArticleAlvotech与BiosanaPharma达成全球独家许可协议,共同开发Xolair®(奥马珠单抗)的拟议生物仿制药(AVT23)
冰岛雷克雅未克和荷兰莱顿 (美国商业资讯)–完全专注于为全球患者开发和生产生物仿制药的全球性生物制药公司Alvotech Holdings S.A. (“Alvotech”)已经与BiosanaPharma达成了一项全球独家许可协议,共同开发Xolair®(奥马珠单抗)的拟议生物仿制药AVT23(也称BP001)。 本新闻稿包含多媒体。此处查看新闻稿全文:...
View ArticleAKSO and Huadong Medicine Announce Strategic Collaboration to Develop and...
LOS ANGELES & LONDON & HANGZHOU, China AKSO Biopharmaceutical, Inc. (“AKSO”), a global biopharmaceutical company with an innovative and comprehensive approach to treat cancer, autoimmune...
View ArticleOrum Therapeutics to Participate in February Investor Conferences
BOSTON & DAEJEON, South Korea Orum Therapeutics, a biotechnology company pioneering the development of tumor-directed targeted protein degraders, today announced that the Company’s leadership...
View ArticleEdiGene Announces Publication by Company Scientific Founder in Nature...
BEIJING & CAMBRIDGE, Mass. EdiGene, Inc., a global biotechnology company, today announced its Scientific Founder Wensheng Wei’s lab at Peking University has published a research article in...
View Article雷迪博士实验室达成收购德国医用大麻公司Nimbus Health GmbH的最终协议
德国法兰克福和印度海德拉巴 (美国商业资讯)–雷迪博士实验室有限公司(Dr. Reddy’s Laboratories Ltd., BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY,连同其子公司一起称为“雷迪博士”)今天宣布已达成一项收购Nimbus Health GmbH(简称“Nimbus Health”)的最终协议。Nimbus...
View ArticleUAEの大手ヘルスケア企業VPSヘルスケアが世界的拡大と教育・研究への投資を視野に活動
アラブ首長国連邦ドバイ (ビジネスワイヤ) — UAEの大手ヘルスケアグループとしてアブダビに本社を置くVPSヘルスケアは、新しい世界市場へと大胆に拡大しようと準備中であり、UAEのヘルスケアを向上させたのと同じ個別化ケアや専門力を世界に届けようとしています。この発表は、3月28~30日のドバイ万博の期間中にドバイ展示センターで開催される世界政府サミットに先立って行いました。...
View ArticleGuided Therapeutics Announces Testing Completion of First 150 Patients in...
PEACHTREE CORNERS, Ga. Guided Therapeutics, Inc. (OTCQB: GTHP), the maker of the LuViva Advanced Cervical Scan, announced today that testing of 150 patients has been completed in the ongoing...
View ArticlePrestige Biopharma Receives 2022 Asia-Pacific Bioprocessing Excellence Awards
SINGAPORE Prestige Biopharma Limited a Singapore-based leading biopharmaceutical with operations in USA and South Korea, announced that the company has been recognized as the grand winner of the...
View ArticleAccutar Biotechnology Receives NMPA Clearance of IND Application for AC0682...
BROOKLYN, N.Y. & SHANGHAI Accutar Biotechnology, Inc., a clinical stage biotechnology company focusing on artificial intelligence (AI)-empowered drug discovery, announces that the China National...
View ArticleOrum Therapeutics Announces Formation of Scientific Advisory Board
BOSTON & DAEJEON, South Korea Orum Therapeutics, a biotechnology company pioneering the development of tumor-directed targeted protein degraders to treat cancer, today announced the formation of...
View ArticleDNA Script Partners with Asia-Pacific Distributors as Part of Global...
SOUTH SAN FRANCISCO, Calif. & PARIS DNA Script, a world leader in Enzymatic DNA Synthesis (EDS) for DNA on demand, has reached agreements with several leading biotechnology distribution...
View ArticleUSound推出基于微机电系统的对患者安全的扬声器,可用于磁共振成像兼容耳机
奥地利格拉茨 (美国商业资讯)–为个人设备和可穿戴技术开发微机电系统(MEMS)扬声器的全球性公司USound宣布进军健康科技行业,将推出完全适用于磁共振成像兼容耳机和配件的MEMS扬声器。 本新闻稿包含多媒体。此处查看新闻稿全文: https://www.businesswire.com/news/home/20220404005545/zh-CN/ USound MEMS...
View ArticlePropanc Biopharma’s CEO Expresses Concern Over Disruption to Cancer Care...
MELBOURNE, Australia Propanc Biopharma, Inc. (OTCQB: PPCB) (“Propanc” or the “Company”), a biopharmaceutical company developing novel cancer treatments for patients suffering from recurring and...
View ArticleMichael Krams, M.D.加入Exscientia担任首席定量医学官
英格兰牛津 (美国商业资讯)–Exscientia plc (Nasdaq: EXAI)今天宣布任命医学博士Michael Krams,...
View ArticleAlvotech和STADA与艾伯维解决欧洲专利纠纷,为Humira®的无柠檬酸盐、高浓度生物仿制药HUKYNDRA®(AVT02)上市铺平道路
冰岛雷克雅未克和德国巴特菲尔伯尔 (美国商业资讯)–Alvotech Holdings S.A....
View ArticleLevitasBio发布LeviCell EOS系统:开启样本处理和定性新时代
加利福尼亚州门洛帕克 (美国商业资讯)–LevitasBio, Inc.今天发布了LeviCell™ EOS系统,这是该公司的新一代细胞分离和富集解决方案,具有更高的通量和活性细胞同步靶向选择。利用经过现场验证的悬浮技术,研究人员现在能有效地将实验规模扩增16倍,每次运行处理多达4000万个细胞。LeviCell...
View ArticleBeiGene to Present Clinical Results and Biomarker Data on Tislelizumab in...
CAMBRIDGE, Mass. & BEIJING & BASEL, Switzerland BeiGene (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global, science-driven biotechnology company focused on developing innovative and...
View ArticleアルヴォテックとSTADA、アッヴィとの欧州特許紛争を解決してHumira®のクエン酸フリー高濃度バイオシミラーHUKYNDRA®(AVT02)発売への道を開く
アイスランド・レイキャビク & 独バートフィルベル (ビジネスワイヤ) —...
View Article